Ayodeji Idowu

Ayodeji Idowu

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2019 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
AIAyodeji Idowu
Ayodeji Idowu
AMAsisipho Mzukwa
Asisipho Mzukwa
UHUte Harrison
Ute Harrison
PPPia Palamides
Pia Palamides
RHRainer Haas
Rainer Haas
HNHenry Njom
Henry Njom
The global prevalence of H. pylori approaches 50%, with prevalence rates between 20 and 40% in developed countries and up to 90% in Africa and other developing nations of the world. Development of H. pylori-associated diseases is determined by a number of virulence factors. This study aimed at determining the prevalence of H. pylori infections and virulence genes (cagA, dupA, and vacA); the relationship between virulence factors and gastroduodenal diseases among patients. Gastric biopsies were obtained from patients and cultured, DNA was extracted from cultured isolates and biopsies for PCR assay after which samples were investigated using standard laboratory procedures. Data of associated risk factors were obtained with the aid of questionnaires. Of the 444 participants, H. pylori was detected in 115 (25.9%) from culture analysis and 217 (48.9%) by direct PCR method. Ninety-eight (85.2%) of the culture-positive patients were also detected by PCR giving an overall prevalence of 52.7% (234/444). The highest number of H. pylori isolates 76.9% (180/234) was obtained from patients suffering from pangastritis. The CagA virulence gene was found in 62% (145/234), dupA in 53.4% (125/234) and vacA in 90.6% (212/234). VacA genotype s1 m1 was the most prevalent [56.4% (132)] followed by s2 m2 [11.5% (27)], s2 m1 [10.3% (24)] and [s1 m2 9.4% (22)]. There was a significant association observed in vacA s1 and peptic ulcer disease, as well as vacA s1/m2 and gastric erosion (P < 0.05). The study revealed a significant association between virulence genes and the development of certain forms of gastric infections while the variations in H. pylori detection and the associated risk factors investigated in the study were not significantly related.

1 January 2019 in Minerva Gastroenterologica E Dietologica
Verified
Journal Article
Closed access
SSStella Smith
Stella Smith
TJTolulope Jolaiya
Tolulope Jolaiya
COCharles Onyekwere
Charles Onyekwere
MFMuinah Fowora
Muinah Fowora
RURose Ugiagbe
Rose Ugiagbe
Rinaldo PellicanoRinaldo Pellicano
Rinaldo Pellicano
BACKGROUND: This multicenter study was undertaken to determine the prevalence of Helicobacter pylori (H. pylori) infection among dyspeptic patients with and without type 2 diabetes mellitus (T2DM). METHODS: Patients with dyspepsia were recruited from tertiary teaching hospitals, three in the South-West and one in the South-South regions of Nigeria, between November 2016 and August 2017. The participants had breath samples analyzed for H. pylori by the Urea Breath Test (UBT) following manufacturer's instructions. Dyspeptic patients who were diagnosed previously with T2DM were recorded. Crosstab using chi-square and correlation analyses were used to test (hypothesis) variables. RESULTS : The entire cohort included 471 dyspeptics, 19 (4%) of whom had T2DM. H. pylori infection was reported in 232/471 (49.3%) dyspeptics and 13/19 T2DM patients, without significant difference between diabetics and nondiabetics. The majority (84.6%) of those positive for UBT and T2DM were in the age group 52-71 years, while none was in the age group 72-91 years. There was no statistical significance (P> 0.05) between the age group, UBT and T2DM positive. CONCLUSIONS : Our study showed that, in Nigeria, there is no difference in prevalence of H. pylori in dyspeptic patients with and without T2DM.

29 February 2020 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
TJTolulope Funbi Jolaiya
Tolulope Funbi Jolaiya
MFMuinah Adenike Fowora
Muinah Adenike Fowora
COCHARLES ASABAMAKA ONYEKWERE
CHARLES ASABAMAKA ONYEKWERE
RURose Ugiagbe
Rose Ugiagbe
IAIfeanyi Ifeoma Agbo
Ifeanyi Ifeoma Agbo
SSStella Smith
Stella Smith
Introduction: Helicobacter pylori is a principal cause of gastric cancer. The aim of this study was to determine the prevalence and contribution of duodenal ulcer promoting gene A (dupA), the plasticity region genes and sigma factors in relation to their pathological expression of H. pylori infections in the Nigerian population. Methodology: Polymerase Chain Reaction was used to analyze a total of forty-nine H. pylori strains isolated from patients attending various endoscopic units in tertiary hospitals in Nigeria for complete dupA (G27 variant), jhp0917, jhp0918, other plasticity region genes jhp 914/917, jhp0914, jhp0940 and sigma factors. Results: PCR results indicated that the prevalence of complete dupA (G27 variants), jhp0917, jhp0918 and other plasticity region genes jhp0914, jhp0914/0917 and jhp0940 in the H. pylori strains were 4%, 53%, 88%, 73%, 12% and 0% respectively. The prevalence values of the sigma factors were 96%, 92%, 80% for rpoN, fliA and rpoD respectively. However, the endoscopic findings showed that erosion, normal mucosal, ulcer, hyperaemic stomach, mucosal atrophy and oedematous stomach in the patients where the H. pylori strains were isolated were 40.8%, 32.7%, 10.2%, 8.2%, 2.0% and 6.1% respectively. There was significant association between jhp0917, jhp914/917 and G27 variant and the endoscopic findings, while other plasticity genes showed no association with the endoscopic findings. Conclusion: These results suggest that the presence of jhp0917, jhp0914/917 and G27 variant could be used as marker to predict the pathological effect of severity in Nigeria patients with H. pylori infection.

18 July 2012 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Closed access
FAFestus D. Adu
Festus D. Adu
AIAyodeji Idowu
Ayodeji Idowu
AAAderonke K. Akintokun
Aderonke K. Akintokun
JAJohnson A. Adeniji
Johnson A. Adeniji
BABolajoko O. Ajuwon
Bolajoko O. Ajuwon